NO853407L - Preparat med kontrollert utskillelse av virkestoff. - Google Patents

Preparat med kontrollert utskillelse av virkestoff.

Info

Publication number
NO853407L
NO853407L NO853407A NO853407A NO853407L NO 853407 L NO853407 L NO 853407L NO 853407 A NO853407 A NO 853407A NO 853407 A NO853407 A NO 853407A NO 853407 L NO853407 L NO 853407L
Authority
NO
Norway
Prior art keywords
active substance
preparation
drug
tablet
control separation
Prior art date
Application number
NO853407A
Other languages
English (en)
Other versions
NO169996C (no
NO169996B (no
Inventor
Bo Magnus Ekman
Aake Richard Lindahl
Original Assignee
Leo Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Leo Ab filed Critical Leo Ab
Publication of NO853407L publication Critical patent/NO853407L/no
Publication of NO169996B publication Critical patent/NO169996B/no
Publication of NO169996C publication Critical patent/NO169996C/no

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2072Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A61K9/209Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Control Of Temperature (AREA)
  • Slot Machines And Peripheral Devices (AREA)
  • Processes Of Treating Macromolecular Substances (AREA)
NO853407A 1984-09-06 1985-08-29 Fremgangsmaate ved fremstilling av et farmasoeytisk preparat med kontrollert utskillelse av virkestoff NO169996C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE8404467A SE8404467D0 (sv) 1984-09-06 1984-09-06 Controlled-release medical preparations

Publications (3)

Publication Number Publication Date
NO853407L true NO853407L (no) 1986-03-07
NO169996B NO169996B (no) 1992-05-25
NO169996C NO169996C (no) 1992-09-02

Family

ID=20356934

Family Applications (1)

Application Number Title Priority Date Filing Date
NO853407A NO169996C (no) 1984-09-06 1985-08-29 Fremgangsmaate ved fremstilling av et farmasoeytisk preparat med kontrollert utskillelse av virkestoff

Country Status (21)

Country Link
US (1) US4824678A (no)
EP (1) EP0173928B1 (no)
JP (1) JP2527713B2 (no)
KR (1) KR930003114B1 (no)
AT (1) ATE53490T1 (no)
AU (1) AU576891B2 (no)
CA (1) CA1252723A (no)
DE (1) DE3578123D1 (no)
DK (1) DK164256C (no)
ES (1) ES8702138A1 (no)
FI (1) FI87042C (no)
GR (1) GR852158B (no)
HU (1) HU194495B (no)
IE (1) IE58263B1 (no)
IL (2) IL76256A (no)
NO (1) NO169996C (no)
NZ (1) NZ213245A (no)
PH (1) PH22119A (no)
PT (1) PT81092B (no)
SE (1) SE8404467D0 (no)
ZA (1) ZA856547B (no)

Families Citing this family (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4917899A (en) * 1983-12-22 1990-04-17 Elan Corporation Plc Controlled absorption diltiazem formulation
IE56999B1 (en) * 1983-12-22 1992-03-11 Elan Corp Plc Pharmaceutical formulation
DK62184D0 (da) * 1984-02-10 1984-02-10 Benzon As Alfred Diffusionsovertrukket polydepotpraeparat
JPH0759499B2 (ja) * 1984-02-10 1995-06-28 ベンツォン ファーマ エイ/エス 拡散被覆された複合単位服用剤
US5624683A (en) * 1986-08-06 1997-04-29 Eisai Co., Ltd. Sustained-release multi-granule tablet
DE3720757A1 (de) * 1987-06-24 1989-01-05 Bayer Ag Dhp-manteltablette
US5073381A (en) * 1988-08-15 1991-12-17 University Of Akron Amphiphilic networks
US5612059A (en) * 1988-08-30 1997-03-18 Pfizer Inc. Use of asymmetric membranes in delivery devices
SE8803822D0 (sv) * 1988-10-26 1988-10-26 Novel dosage form
US5178868A (en) * 1988-10-26 1993-01-12 Kabi Pharmacia Aktiebolaq Dosage form
US5240601A (en) * 1988-11-09 1993-08-31 Chembiomed, Ltd. Affinity supports for hemoperfusion
US5149425A (en) * 1988-11-09 1992-09-22 Chembiomed, Ltd. Affinity supports for hemoperfusion
DK0542926T3 (da) * 1990-08-07 1995-05-15 Pfizer Brug af grænsefladepolymeriserede membraner i frigivelsesanordninger
US5288505A (en) * 1991-06-26 1994-02-22 Galephar P.R., Inc., Ltd. Extended release form of diltiazem
US5407686A (en) * 1991-11-27 1995-04-18 Sidmak Laboratories, Inc. Sustained release composition for oral administration of active ingredient
GB2267219B (en) * 1992-05-28 1996-04-03 Elan Corp Plc Differential release tablet with multiple active agents
CA2157793C (en) * 1993-03-09 1999-07-13 James E. Woiszwillo Macromolecular microparticles and methods of production
US6090925A (en) 1993-03-09 2000-07-18 Epic Therapeutics, Inc. Macromolecular microparticles and methods of production and use
US5547948A (en) * 1995-01-17 1996-08-20 American Home Products Corporation Controlled release of steroids from sugar coatings
EP1005863A1 (en) * 1998-12-04 2000-06-07 Synthelabo Controlled-release dosage forms comprising a short acting hypnotic or a salt thereof
EP1064937A1 (en) * 1999-06-28 2001-01-03 Sanofi-Synthelabo Timed dual release dosage forms comprising a short acting hypnotic or a salt thereof
GB9923045D0 (en) * 1999-09-29 1999-12-01 Novartis Ag New oral formulations
US20060153914A1 (en) * 1999-12-10 2006-07-13 Biovail Laboratories International S.R.L. Chronotherapeutic diltiazem formulations and the administration thereof
US7108866B1 (en) 1999-12-10 2006-09-19 Biovall Laboratories International Srl Chronotherapeutic diltiazem formulations and the administration thereof
WO2001045668A2 (en) 1999-12-20 2001-06-28 Schering Corporation Stable extended release oral dosage composition comprising pseudoephedrine and desloratadine
AU2276801A (en) 1999-12-20 2001-07-03 Schering Corporation Extended release oral dosage composition
SE0100200D0 (sv) 2001-01-24 2001-01-24 Astrazeneca Ab New film coating
US6960357B2 (en) 2001-05-25 2005-11-01 Mistral Pharma Inc. Chemical delivery device
MXPA03012041A (es) * 2001-07-04 2004-03-26 Sun Pharmaceutical Ind Ltd Sistema de administracion controlada de farmacos de retencion gastrica.
US6602911B2 (en) 2001-11-05 2003-08-05 Cypress Bioscience, Inc. Methods of treating fibromyalgia
ES2233876T3 (es) * 2001-12-19 2005-06-16 Astrazeneca Ab Nuevo recubrimiento de pelicula que contiene un copolimero acrilato de etilo/metacrilato de metilo y poli (acetato de vinilo).
US20030203055A1 (en) * 2002-03-15 2003-10-30 Cypress Bioscience, Inc. Methods of treating visceral pain syndromes
US20060003004A1 (en) * 2002-10-25 2006-01-05 Collegium Pharmaceutical, Inc. Pulsatile release compositions of milnacipran
US20040132826A1 (en) * 2002-10-25 2004-07-08 Collegium Pharmaceutical, Inc. Modified release compositions of milnacipran
GB0227948D0 (en) * 2002-11-29 2003-01-08 Cipla Ltd Pharmaceutical combinations comprising b-2 adrenoreceptor agonists and xanthines
WO2004067039A1 (en) * 2003-01-28 2004-08-12 Collegium Pharmaceutical, Inc. Multiparticulate compositions of milnacipran for oral administration
US7862835B2 (en) * 2004-10-27 2011-01-04 Boston Scientific Scimed, Inc. Method of manufacturing a medical device having a porous coating thereon
US7994220B2 (en) * 2005-09-28 2011-08-09 Cypress Bioscience, Inc. Milnacipran for the long-term treatment of fibromyalgia syndrome
US8148393B2 (en) * 2005-11-18 2012-04-03 Synthon Bv Zolpidem tablets
US7427414B2 (en) * 2006-01-18 2008-09-23 Astron Research Limited Modified release oral dosage form using co-polymer of polyvinyl acetate
CN102440992A (zh) * 2011-12-19 2012-05-09 岳阳新华达制药有限公司 含有盐酸班布特罗和多索茶碱复方制剂及其制备方法
EP3331502B1 (en) 2015-08-07 2021-05-26 Santa Farma Ilaç Sanayi A.S. Controlled release propiverine formulations
WO2020101586A1 (en) 2018-11-16 2020-05-22 Santa Farma İlaç Sanayi̇ A.Ş. Controlled release propiverine formulations
WO2022115056A1 (en) 2020-11-27 2022-06-02 Santa Farma Ilac Sanayii A.S. Sustained release formulation compositions comprising propiverine

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL108838C (no) * 1956-03-27
US3538214A (en) * 1969-04-22 1970-11-03 Merck & Co Inc Controlled release medicinal tablets
EP0013131A3 (en) * 1978-12-27 1981-01-07 Mundipharma A.G. Pharmaceutical composition in solid dosage form, and process for its production
US4557925A (en) * 1982-07-08 1985-12-10 Ab Ferrosan Membrane-coated sustained-release tablets and method
JPH075457B2 (ja) * 1983-08-16 1995-01-25 ザ ウエルカム フアウンデ−シヨン リミテツド 調節された方法による有効成分の放出を可能にする医薬組成物
US4769027A (en) * 1984-08-15 1988-09-06 Burroughs Wellcome Co. Delivery system

Also Published As

Publication number Publication date
AU576891B2 (en) 1988-09-08
AU4693585A (en) 1986-03-13
IL76257A (en) 1989-05-15
DK400685A (da) 1986-03-07
JPS61112013A (ja) 1986-05-30
ES8702138A1 (es) 1986-12-16
PH22119A (en) 1988-06-01
PT81092B (pt) 1988-01-22
ZA856547B (en) 1986-04-30
NZ213245A (en) 1988-06-30
NO169996C (no) 1992-09-02
ATE53490T1 (de) 1990-06-15
IL76256A0 (en) 1986-01-31
FI853406A0 (fi) 1985-09-05
DK400685D0 (da) 1985-09-02
PT81092A (en) 1985-10-01
IL76256A (en) 1990-06-10
GR852158B (no) 1986-01-08
DE3578123D1 (de) 1990-07-19
DK164256B (da) 1992-06-01
ES546728A0 (es) 1986-12-16
FI87042C (fi) 1992-11-25
IE852070L (en) 1986-03-06
FI87042B (fi) 1992-08-14
IE58263B1 (en) 1993-08-25
EP0173928A1 (en) 1986-03-12
US4824678A (en) 1989-04-25
SE8404467D0 (sv) 1984-09-06
KR860002271A (ko) 1986-04-24
EP0173928B1 (en) 1990-06-13
HUT40333A (en) 1986-12-28
FI853406L (fi) 1986-03-07
NO169996B (no) 1992-05-25
KR930003114B1 (ko) 1993-04-19
DK164256C (da) 1992-10-19
JP2527713B2 (ja) 1996-08-28
HU194495B (en) 1988-02-29
CA1252723A (en) 1989-04-18

Similar Documents

Publication Publication Date Title
NO853407L (no) Preparat med kontrollert utskillelse av virkestoff.
CA2281420A1 (en) Preparation of pharmaceutically-active granules
IE883810L (en) Sustained release pharmaceutical compositions
ATE150963T1 (de) Kugelförmige granula mit kern sowie deren herstellung
DE3767600D1 (de) Ibuprofen-formulation mit verzoegerter wirkstoffabgabe.
FI864108A (fi) Nytt farmaceutiskt preparat och foerfarande foer framstaellning av detsamma.
KR910011242A (ko) 서방성 약학제제 및 그의 제조방법
DE59806578D1 (de) Verwendung von redispergierbaren Polymerpulvern oder Polymergranulaten zum Überziehen von pharmazeutischen oder agrochemischen Darreichungsformen
KR880001289A (ko) 서방성 제제 및 그의 제조방법
CA2045358A1 (en) Controlled release pharmaceutical preparation
ATE56143T1 (de) Verfahren zur herstellung einer waessrigen ueberzugsmitteldispersion und ihre verwendung zum ueberziehen von arzneimitteln.
CA2000932A1 (en) Oral pharmaceutical controlled release multiple unit dosage form
NO170424C (no) Harpikspartikler av desintegrasjonstypen, deres fremstilling og beleggsmiddel inneholdende slike partikler
ATE72974T1 (de) Diltiazem-mikrokugeln, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische zusammensetzungen mit gesteuerter abgabe.
GR3018795T3 (en) Emulsion-free emulsion polymers in sustained-release pharmaceutical compositions and their production
JPS5549312A (en) Preparation of slow-releasing medicine

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees

Free format text: LAPSED IN FEBRUARY 2002